PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
14561475-3	2003	In this study, a binary phase diagram of hydrated mixtures of N-palmitoylethanolamine (NP-E)--an endogenous ligand for the peripheral cannabinoid receptor (CB-2)--with dipalmitoylphosphatidylcholine (DPPC) is established by high-sensitivity differential scanning calorimetry (DSC).	palmidrol	62-85	cannabinoid receptor 2	Homo sapiens	156-160	
9685157-3	1998	Palmitylethanolamide (PEA), which is released together with anandamide from a common phospholipid precursor, exerts a similar effect by activating peripheral CB2-like receptors.	palmidrol	0-20	cannabinoid receptor 2	Homo sapiens	158-161	
10469888-4	1999	The capability of palmitoylethanolamide, an anti-inflammatory metabolite, to activate CB2-like receptors is still being debated.	palmidrol	18-39	cannabinoid receptor 2	Homo sapiens	86-89	
9685157-3	1998	Palmitylethanolamide (PEA), which is released together with anandamide from a common phospholipid precursor, exerts a similar effect by activating peripheral CB2-like receptors.	palmidrol	22-25	cannabinoid receptor 2	Homo sapiens	158-161	
28336953-0	2017	Palmitoylethanolamide induces microglia changes associated with increased migration and phagocytic activity: involvement of the CB2 receptor.	palmidrol	0-21	cannabinoid receptor 2	Homo sapiens	128-131	
7724569-7	1995	Although both palmitoylethanolamide and anandamide bind to the CB2 receptor, only the former downmodulates mast cell activation in vitro.	palmidrol	14-35	cannabinoid receptor 2	Homo sapiens	63-66	
25598150-1	2016	BACKGROUND AND PURPOSE: Palmitoylethanolamide (PEA) is an endogenous congener of anandamide and potentiates its actions at cannabinoid CB1 and CB2 receptors, and at transient receptor potential vanilloid type-1 (TRPV1) channels.	palmidrol	24-45	cannabinoid receptor 2	Homo sapiens	143-146	
25598150-1	2016	BACKGROUND AND PURPOSE: Palmitoylethanolamide (PEA) is an endogenous congener of anandamide and potentiates its actions at cannabinoid CB1 and CB2 receptors, and at transient receptor potential vanilloid type-1 (TRPV1) channels.	palmidrol	47-50	cannabinoid receptor 2	Homo sapiens	143-146